Adherence inhibition of enteric pathogens to epithelial cells by bovine colostrum fractions

International Dairy Journal

Volumn 40, Issue , 2015, Pages 24-32

  Maldonado Gomez, Maria X ^a   Lee, Hyeyoung ^b   Barile, Daniela ^b   Lu, Mei ^a   Hutkins, Robert W ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENTERIC PATHOGENS; EPITHELIAL CELLS;

EID: 84908316108     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2014.08.014     Document Type: Article

References (76)

1. Aberg V., Almqvist F. Pilicides-small molecules targeting bacterial virulence. Organic and Biomolecular Chemistry 2007, 5:1827-1834.
2. Aldredge D.L., Geronimo M.R., Hua S., Nwosu C.C., Lebrilla C.B., Barile D. Annotation and structural elucidation of bovine milk oligosaccharides and determination of novel fucosylated structures. Glycobiology 2013, 23:664-676.
3. An Y.H., Dickinson R.B., Doyle R.J. Mechanisms of bacterial adhesion and pathogenesis of implant and tissue infections. Handbook of bacterial adhesion: Principles, methods, and applications 2000, 1-27. Humana Press, Totowa, N.J., USA. Y.H. An, R.J. Friedman (Eds.).
4. de Araújo A.N., Giugliano L.G. Lactoferrin and free secretory component of human milk inhibit the adhesion of enteropathogenic Escherichia coli to HeLa cells. BMC Microbiology 2001, 1:25.
5. Bao Y., Zhu L., Newburg D.S. Simultaneous quantification of sialyloligosaccharides from human milk by capillary electrophoresis. Analytical Biochemistry 2007, 370:206-214.
6. Barile D., Tao N., Lebrilla C.B., Coisson J.D., Arlorio M., German J.B. Permeate from cheese whey ultrafiltration is a source of milk oligosaccharides. International Dairy Journal 2009, 19:524-530.
7. Bode L. Recent advances on structure metabolism and function of human milk oligosaccharides. Journal of Nutrition 2006, 136:2127-2130.
8. Boehm G., Moro G. Structural and functional aspects of prebiotics used in infant nutrition. Journal of Nutrition 2008, 138:1818S-1828S.
9. Bouckaert J., Berglund J., Schembri M., De Genst E., Cools L., Wuhrer M., et al. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Molecular Microbiology 2005, 55:441-455.
10. Bowen A.B., Braden C.R. Invasive Enterobacter sakazakii disease in infants. Emerging Infectious Diseases 2006, 12:1185-1189.
11. Brody E.P. Biological activities of bovine glycomacropeptide. British Journal of Nutrition 2000, 84:S39-S46.
12. Brück W.M., Kelleher S.L., Gibson G.R., Graverholt G., Lönnerdal B.L. The effects of α-lactalbumin and glycomacropeptide on the association of CaCo-2 cells by enteropathogenic Escherichia coli, Salmonella typhimurium and Shigella flexneri. FEMS Microbiology Letters 2006, 259:158-162.
13. Chaplin M.F., Kennedy J.F. Carbohydrate analysis: A practical approach 1986, (Chapt. 1), IRL Press, Washington, DC, USA.
14. Chichlowski M., German J.B., Lebrilla C.B., Mills D.A. The influence of milk oligosaccharides on microbiota of infants: opportunities for formulas. Annual Review of Food Science and Technology 2011, 2:331-351.
15. Connell H., Hedlund M., Agace W., Svanborg C. Bacterial attachment to uro-epithelial cells: mechanisms and consequences. Advances in Dental Research 1997, 11:50-58.
16. Coppa G.V., Zampini L., Galeazzi T., Facinelli B., Ferrante L., Capretti R., et al. Human milk oligosaccharides inhibit the adhesion to CaCo-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae and Salmonella fyris. Pediatric Research 2006, 59:377-382.
17. Cravioto A., Tello A., Villafán H., Ruiz J., del Vedovo S., Neeser J.R. Inhibition of localized adhesion of enteropathogenic Escherichia coli to HEp-2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk. Journal of Infectious Diseases 1991, 163:1247-1255.
18. Donnenberg M.S., Finlay B.B. Combating enteropathogenic Escherichia coli (EPEC) infections: the way forward. Trends in Microbiology 2013, 21:317-319.
19. Fàbrega A., Vila J. Salmonella enterica serovar Typhimurium skills to succeed in the host: virulence and regulation. Clinical Microbiology Reviews 2013, 6:308-341.
20. Ganan M., Carrascosa A.V., Pascual-Teresa S., Martinez-Rodriguez A.J. Inhibition by yeast-derived mannoproteins of adherence to and invasion of caco-2 cells by Campylobacter jejuni. Journal of Food Protection 2009, 72:55-59.
21. Ganan M., Collins M., Rastall R., Hotchkiss A.T., Chau H.K., Carrascosa A.V., et al. Inhibition by pectic oligosaccharides of the invasion of undifferentiated and differentiated Caco-2 cells by Campylobacter jejuni. International Journal of Food Microbiology 2010, 137:181-185.
22. Ghosh S., Mehla R.K. Influence of dietary supplementation of prebiotics (mannanoligosaccharide) on the performance of crossbred calves. Tropical Animal Health and Production 2012, 44:617-662.
23. Halpin R.M., Brady D.B., O'Riordan E.D., O'Sullivan M. Untreated and enzyme-modified bovine whey products reduce association of Salmonella Typhimurium, Escherichia coli O157:H7 and Cronobacter malonaticus (formerly Enterobacter sakazakii) to CaCo-2 cells. Journal of Applied Microbiology 2010, 108:406-415.
24. Healy B., Cooney S., O'Brien S., Iversen C., Whyte P., Nally J., et al. Cronobacter (Enterobacter sakazakii): an opportunistic foodborne pathogen. Foodborne Pathogens and Disease 2010, 7:339-350.
25. Hickey R.M. The role of oligosaccharides from human milk and other sources in prevention of pathogen adhesion. International Dairy Journal 2012, 22:141-146.
26. Klemm P., Roos V., Ulett G.C., Svanborg C., Schembri M.A. Molecular characterization of the Escherichia coli asymptomatic bacteria strain 83972: the taming of a pathogen. Infection and Immunity 2006, 74:781-785.
27. Klemm P., Vejborg R.M., Hancock V. Prevention of bacterial adhesion. Applied Microbiology and Biotechnology 2010, 88:451-459.
28. Kline K.A., Fälker S., Dahlberg S., Normark S., Henriques-Normark B. bacterial adhesins in host-microbe interactions. Cell Host and Microbe 2009, 5:580-592.
29. Korea C.G., Ghigo J.M., Beloin C. The sweet connection: solving the riddle of multiple sugar-binding fimbrial adhesins in Escherichia coli: multiple E.coli fimbriae form a versatile arsenal of sugar-binding lectins potentially involved in surface-colonization and tissue tropism. Bioessays 2011, 33:300-311.
30. Krachler A.M., Orth K. Targeting the bacteria-host interface: strategies in anti-adhesion therapy. Virulence 2013, 4:284-294.
31. Kuntz S., Kunz C., Rudloff S. Oligosaccharides from human milk induce growth arrest via G2/M by influencing growth-related cell cycle genes in intestinal epithelial cells. British Journal of Nutrition 2009, 101:1306-1315.
32. Kunz C., Rudloff S., Baier W., Klein N., Strobel S. Oligosaccharides in human milk: structural functional and metabolic aspects. Annual Review of Nutrition 2000, 20:699-722.
33. Kvistgaard A.S., Pallesen L.T., Arias C.F., López S., Petersen T.E., Heegaard C.W., et al. Inhibitory effects of human and bovine milk constituents on rotavirus infections. Journal of Dairy Science 2004, 87:4088-4096.
34. Lane J.A., Mariño K., Naughton J., Kavanaugh D., Clyne M., Carrington S.D., et al. Anti-infective bovine colostrum oligosaccharides: Campylobacter jejuni as a case study. International Journal of Food Microbiology 2012, 157:182-188.
35. Lane J.A., Mariño K., Rudd P.M., Carrington S.D., Slattery H., Hickey R.M. Methodologies for screening of bacteria-carbohydrate interactions: anti-adhesive milk oligosaccharides as a case study. Journal of Microbiological Methods 2012, 90:53-59.
36. Lane J.A., O'Callaghan J., Carrington S.D., Hickey R.M. Transcriptional response of HT-29 intestinal epithelial cells to human and bovine milk oligosaccharides. British Journal of Nutrition 2013, 28:1-11.
37. Langermann S., Ballou W.R. Development of a recombinant FimCH vaccine for urinary tract infections. Advances in Experimental Medicine and Biology 2003, 539:635-648.
38. Larsson A., Johansson S.M., Pinkner J.S., Hultgren S.J., Almqvist F., Kihlberg J., et al. Multivariate design synthesis and biological evaluation of peptide inhibitors of FimC/FimH protein-protein interactions in uropathogenic Escherichia coli. Journal of Medicinal Chemistry 2005, 48:935-945.
39. LoCascio R.G., Ninonuevo M.R., Freeman S.L., Sela D.A., Grimm R., Lebrilla C.B., et al. Glycoprofiling of bifidobacterial consumption of human milk oligosaccharides demonstrates strain specific preferential consumption of small chain glycans secreted in early human lactation. Journal of Agricultural and Food Chemistry 2007, 55:8914-8919.
40. Manthey C.F., Autran C.A., Eckmann L., Bode L. Human milk oligosaccharides protect against enteropathogenic Escherichia coli attachment invitro and EPEC colonization in suckling mice. Journal of Pediatric Gastroenterology and Nutrition 2014, 58:167-170.
41. Marcobal A., Barboza M., Froehlich J.W., Block D.E., German J.B., Lebrilla C.B., et al. Consumption of human milk oligosaccharides by gut-related microbes. Journal of Agricultural and Food Chemistry 2010, 58:5334-5340.
42. Martin-Sosa S., Martin M.J., Hueso P. The sialylated fraction of milk oligosaccharides is partially responsible for binding to enterotoxigenic and uropathogenic Escherichia coli human strains. Journal of Nutrition 2002, 132:3067-3072.
43. Martínez I., Wallace G., Zhang C., Legge R., Benson A.K., Carr T.P., et al. Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota. Applied and Environmental Microbiology 2009, 75:4175-4184.
44. Morrow A.L., Ruiz-Palacios G.M., Jiang X., Newburg D.S. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. Journal of Nutrition 2005, 135:1304-1307.
45. Nagahori N., Lee R.T., Nishimura S., Pagé D., Roy R., Lee Y.C. Inhibition of adhesion of type 1 fimbriated Escherichia coli to highly mannosylated ligands. ChemBiochem 2002, 3:836-844.
46. Nakajima K., Tamura N., Kobayashi-Hattori K., Yoshida T., Hara-Kudo Y., Ikedo M., et al. Prevention of intestinal infection by glycomacropeptide. Bioscience Biotechnology and Biochemistry 2005, 69:2294-2301.
47. Newburg D.S., Peterson J.A., Ruiz-Palacios G.M., Matson D.O., Morrow A.L., Shults J., et al. Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Lancet 1998, 351:1160-1164.
48. Newburg D.S., Ruiz-Palacios G.M., Morrow A.L. Human milk glycans protect infants against enteric pathogens. Annual Review of Nutrition 2005, 25:37-58.
49. Ofek I., Hasty D.L., Doyle R.J. Bacterial adhesion to animal cells and tissues 2003, (Chapt. 1), ASM Press, Washington, DC, USA.
50. Ouwehand A.C., Conway P.L., Salminen S.J. Inhibition of S-fimbria-mediated adhesion to human ileostomy glycoproteins by a protein isolated from bovine colostrum. Infection and Immunity 1995, 63:4917-4920.
51. Ouwehand A.C., Salminen S.J. Adhesion inhibitory activity of β-lactoglobulin isolated from infant formulae. Acta Paediatrica 1998, 87:491-493.
52. Ouwehand A.C., Salminen S.J., Skurnik M., Conway P.L. Inhibition of pathogen adhesion by β-lactoglobulin. International Dairy Journal 1997, 7:685-692.
53. Pinkner J.S., Remaut H., Buelens F., Miller E., Aberg V., Pemberton N., et al. Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:17897-17902.
54. Quintero M., Maldonado M., Perez-Munoz M., Jimenez R., Fangman T., Rupnow J., et al. Adherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by prebiotic oligosaccharides. Current Microbiology 2011, 62:1448-1454.
55. Quintero-Villegas M.I., Aam B.B., Rupnow J., Sørlie M., Eijsink V.G., Hutkins R.W. Adherence inhibition of enteropathogenic Escherichia coli by chitooligosaccharides with specific degrees of acetylation and polymerization. Journal of Agricultural and Food Chemistry 2013, 61:2748-2754.
56. Rasko D.A., Sperandio V. Anti-virulence strategies to combat bacteria-mediated disease. Nature Reviews Drug Discovery 2010, 2:117-128.
57. Rescigno M., Sabatino A.D. Dendritic cells in intestinal homeostasis and disease. Journal of Clinical Investigation 2009, 119:2441-2450.
58. Roos V., Nielsen E.M., Klemm P. Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition. FEMS Microbiology Letters 2006, 262:22-30.
59. Rutter J.M., Jones G. Protection against enteric disease caused by Escherichia coli: a model for vaccination with a virulence determinant?. Nature 1973, 242:531-532.
60. Ruvoën-Clouet N., Mas E., Marionneau S., Guillon P., Lombardo D., Le Pendu J. Bile-salt-stimulated lipase and mucins from milk of "secretor" mothers inhibit the binding of Norwalk virus capsids to their carbohydrate ligands. Biochemical Journal 2006, 393:627-634.
61. Schembri M.A., Klemm P. Biofilm formation in a hydrodynamic environment by novel FimH variants and ramifications for virulence. Infection and Immunity 2001, 69:1322-1328.
62. Schroten H., Hanisch F.G., Plogmann R., Hacker J., Uhlenbruck G., Nobis-Bosch R., et al. Inhibition of adhesion of S-fimbriated Escherichia coli to buccal epithelial cells by human milk fat globule membrane components: a novel aspect of the protective function of mucins in the nonimmunoglobulin fraction. Infection and Immunity 1992, 60:2893-2899.
63. Schwertmann A., Schroten H., Hacker J., Kunz C. S-Fimbriae from Escherichia coli bind to soluble glycoproteins from human milk. Journal of Pediatric Gastroenterology and Nutrition 1999, 28:257-263.
64. Sela D.A., Li Y., Lerno L., Wu S., Marcobal A.M., German J.B., et al. An infant-associated bacterial commensal utilizes breast milk sialyloligosaccharides. Journal of Biological Chemistry 2011, 286:11909-11918.
65. Shoaf K., Mulvey G.L., Armstrong G.D., Hutkins R.W. Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infection and Immunity 2006, 74:6920-6928.
66. Simon P.M., Goode P.L., Mobasseri A., Zopf D. Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligosaccharides. Infection and Immunity 1997, 65:750-757.
67. Spring P., Wenk C., Dawson K., Newman K. The effects of dietary mannaoligosaccharides on cecal parameters and the concentrations of enteric bacteria in the ceca of salmonella-challenged broiler chicks. Poultry Science 2000, 79:205-211.
68. Superti F., Ammendolia M.G., Valenti P., Seganti L. Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. Medical Microbiology and Immunology 1997, 186:83-91.
69. Superti F., Siciliano R., Rega B., Giansanti F., Valenti P., Antonini G. Involvement of bovine lactoferrin metal saturation sialic acid and protein fragments in the inhibition of rotavirus infection. Biochimica et Biophysica Acta 2001, 1528:107-115.
70. Svensson A., Larsson A., Emtenäs H., Hedenström M., Fex T., Hultgren S.J., et al. Design and evaluation of pilicides: potential novel antibacterial agents directed against uropathogenic Escherichia coli. ChemBioChem 2001, 2:915-918.
71. Tao N., DePeters E.J., German J.B., Grimm R., Lebrilla C.B. Variations in bovine milk oligosaccharides during early and middle lactation stages analyzed by high-performance liquid chromatography-chip/mass spectrometry. Journal of Dairy Science 2009, 92:2991-3001.
72. Urashima T., Saito T., Nakamura T., Messer M. Oligosaccharides of milk and colostrum in non-human mammals. Glycoconjugates Journal 2001, 18:357-371.
73. Wang X., Hirmo S., Willén R., Wadström T. Inhibition of Helicobacter pylori infection by bovine milk glycoconjugates in a BAlb/cA mouse model. Journal of Medical Microbiology 2001, 50:430-435.
74. Ward R.E., Niñonuevo M., Mills D.A., Lebrilla C.B., German J.B. Invitro fermentability of human milk oligosaccharides by several strains of bifidobacteria. Molecular Nutrition and Food Research 2007, 51:1398-1405.
75. Williams, C. E., Hobman, P. G., & Yarrow, S. S. (2005). Colostrum-based composition US Patent 20050220894A1.
76. Yolken R.H., Peterson J.A., Vonderfecht S.L., Fouts E.T., Midthun K., Newburg D.S. Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. Journal of Clinical Investigation 1992, 90:1984-1991.